Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BSND pseudogene 2 (BSNDP2) is classified as a human pseudogene, meaning it is a DNA sequence derived from the functional BSND gene but is nonfunctional and does not encode a functional protein. Pseudogenes like BSNDP2 may arise from gene duplication or retrotransposition events but typically accumulate disabling mutations and lack regulatory elements needed for protein-coding activity. While most pseudogene transcripts have no function, some pseudogenes can affect endogenous gene regulation through RNA-mediated mechanisms or DNA sequence exchange, but no specific biological or clinical role has been established for BSNDP2 itself[1][3][7]. In summary, BSNDP2 is a pseudogene, not a therapeutic target, and contains no known aliases or functional activities beyond its classification as a genomic relic of the parent BSND gene[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BSND pseudogene 2 (BSNDP2).